Showing 1 - 2 results of 2 for search 'Volker Schellenberger', query time: 0.02s Refine Results
  1. 1
    613 HER2-XPAT, a novel protease-activatable prodrug T cell engager (TCE), with potent T-cell activation and efficacy in solid tumors and large predicted safety margins in non-human primate (NHP)

    613 HER2-XPAT, a novel protease-activatable prodrug T cell engager (TCE), with potent T-cell activation and efficacy in solid tumors and large predicted safety margins in non-human... by Fiore Cattaruzza, Ayesha Nazeer, Zachary Lange, Caitlin Koski, Mikhail Hammond, Trang Dao-Pick, Angela Henkensiefken, Mika Derynck, Volker Schellenberger, Bryan Irving

    Published 2020-11-01
    Article
  2. 2
    GLP2-2G-XTEN: a pharmaceutical protein with improved serum half-life and efficacy in a rat Crohn's. PLoS One. 2012; 7(11): e50630.

    GLP2-2G-XTEN: a pharmaceutical protein with improved serum half-life and efficacy in a rat Crohn's. PLoS One. 2012; 7(11): e50630. by Susan E Alters, Bryant McLaughlin, Benjamin Spink, Tigran Lachinyan, Chia-Wei Wang, Vladimir Podust, Volker Schellenberger, Willem P C Stemmer

    Published 2013-01-01
    Get full text
    Article

Search Tools: